HNF1A and type 2 diabetes mellitus: The aim of this current study was to obtain proof-of-concept that miR-224 and miR-103 are detectable in the urine of HNF1A-MODY mutation carriers, and to determine whether these diabetes-associated miRNA are also elevated in the urine of patients with T1DM and T2DM.